K Rao - Dr Reddys President

RDY -- USA Stock  

USD 40.90  0.45  1.11%

  President
Dr. KVS. Ram Rao, Ph.D., serves as a Senior Vice President and Business Head PSAI Commercial Organisation of the Dr. Reddy Laboratories Ltd. He is also leading the Operations transformation effort across all the manufacturing units in our CTO organization
Age: 53  President Since 2016      
91 40 4900 2900  http://www.drreddys.com
Ram Rao joined Dr. Reddy?s as a Manager in the Technical Services Division in 2000 and has contributed significantly in roles like Head of New Product Development API and Head Global Oncology in his thirteen year tenure. Prior to joining us, Dr. Ram Rao had successful stints with Jubilant Life Sciences where he headed the Technical Services Division and Gujarat Heavy Chemicals Limited where he was the Head of R&D. He holds a Ph.D. and a Masters degree in Chemical Engineering from the Indian Institute of Science, Bangalore along with a Bachelors Degree in Chemical Engineering from Osmania University. He also holds a Diploma in Project Management from Narsee Monjee Institute of Management Studies .

Management Efficiency

The company has Return on Asset of 6.98 % which means that on every $100 spent on asset it made $6.98 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 18.75 % implying that it generated $18.75 on every 100 dollars invested.
The company has 811.73 M in debt with debt to equity (D/E) ratio of 20.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.92 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Jay MarkowitzRegeneron Pharmaceuticals
2017
Heidi ChenZoetis
2012
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
John GrayVertex Pharmaceuticals Incorpor
2019
Roxanne LaganoZoetis
2015
James MichaudPerrigo Company Plc
2016
Jatin ShahPerrigo Company Plc
2005
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Alejandro BernalZoetis
2015
Michael PariniVertex Pharmaceuticals Incorpor
2017
Glenn DavidZoetis
2016
Douglas McCorkleRegeneron Pharmaceuticals
2007
Jeffrey NeedhamPerrigo Company Plc
2009
Ian SmithVertex Pharmaceuticals Incorpor
2017
Catherine KnuppZoetis
2012
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Michael AbermanRegeneron Pharmaceuticals
2015
John HendricksonPerrigo Company Plc
2016
Christopher FenimoreRegeneron Pharmaceuticals
2017
John WesolowskiPerrigo Company Plc
2016

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Current Sentiment - RDY

Dr Reddys Laboratories Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Dr Reddys Laboratories Ltd. What is your opinion about investing in Dr Reddys Laboratories Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

V   
Purchased few shares of
few hours ago
Traded for 185.37
FB   
Purchased few shares of
few hours ago
Traded for 194.88
GOOG   
Purchased few shares of
few hours ago
Traded for 1350.8199
TWTR   
Purchased over 100 shares of
few hours ago
Traded for 30.5
MSFT   
Purchased a lot of shares of
few hours ago
Traded for 154.6
Additionally take a look at Your Equity Center. Please also try Companies Directory module to evaluate performance of over 100,000 stocks, funds, and etfs against different fundamentals.
Search macroaxis.com